/POM

POM Stock - POMDOCTOR Ltd

Q: What is the analyst price target for POM?

Analyst price target information is not currently available for POM.

Q: What is POM's market cap?

Market capitalization information is not currently available for POM.

Healthcare|Medical - Pharmaceuticals|NASDAQ

$0.30-2.06%

$0.01 (-2.06%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.33

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for POM

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2021

FY2022

FY2023

FY2024

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.00

52W High$6.43

52W Low$0.26

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021
Revenue	$342.56M	$304.85M	$245.22M	$215.38M
Gross Profit	$47.69M	$38.72M	$54.86M	$52.51M
Gross Margin	13.9%	12.7%	22.4%	24.4%
Operating Income	$-25,791,280	$-22,248,902	$-3,594,279	$-79,668,009
Net Income	$-143,360,926	$-145,390,832	$-125,510,228	$-188,402,525
Net Margin	-41.9%	-47.7%	-51.2%	-87.5%
EPS	$-1.21	$-1.23	$-1.06	$-1.59

Company Overview

Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company's business primarily consists of internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants. The company was founded in 2010 and is headquartered in Guangzhou, China.

Visit Website

Frequently Asked Questions about POM

What is POM's current stock price?

POMDOCTOR Ltd (POM) is currently trading at $0.30 per share. The stock has moved -2.06% today.

What is the analyst price target for POM?

No analyst price targets are currently available for this stock.

What sector is POMDOCTOR Ltd in?

POMDOCTOR Ltd operates in the Healthcare sector, specifically within the Medical - Pharmaceuticals industry. The company is traded on the NASDAQ exchange.

What is POM's market cap?

POMDOCTOR Ltd has a market capitalization of $0.03 billion, making it a small-cap company.

Does POM pay dividends?

No, POMDOCTOR Ltd does not currently pay a dividend to shareholders.